[HTML][HTML] Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects
Z Tian, X Ji, J Liu - International Journal of Molecular Sciences, 2022 - mdpi.com
Vascular cognitive impairment and dementia (VCID) is a major heterogeneous brain
disease caused by multiple factors, and it is the second most common type of dementia in …
disease caused by multiple factors, and it is the second most common type of dementia in …
Brain fog in menopause: a health-care professional's guide for decision-making and counseling on cognition
PM Maki, NG Jaff - Climacteric, 2022 - Taylor & Francis
Midlife women commonly experience changes in their cognitive function as they transition
through menopause and express concern about whether these changes represent the initial …
through menopause and express concern about whether these changes represent the initial …
Global estimates on the number of persons across the Alzheimer's disease continuum
A Gustavsson, N Norton, T Fast, L Frölich… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Global estimates on numbers of persons in early stages of Alzheimer's disease
(AD), including prodromal and preclinical, are lacking, yet are needed to inform policy …
(AD), including prodromal and preclinical, are lacking, yet are needed to inform policy …
[HTML][HTML] X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Although women experience significantly higher tau burden and increased risk for
Alzheimer's disease (AD) than men, the underlying mechanism for this vulnerability has not …
Alzheimer's disease (AD) than men, the underlying mechanism for this vulnerability has not …
[HTML][HTML] Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20–76 years
Sex differences in late-life memory decline may be explained by sex differences in dementia
risk factors. Episodic memory and dementia risk factors were assessed in young, middle …
risk factors. Episodic memory and dementia risk factors were assessed in young, middle …
Effects of tai chi chuan on cognitive function in adults 60 years or older with type 2 diabetes and mild cognitive impairment in China: A randomized clinical trial
Y Chen, J Qin, L Tao, Z Liu, J Huang, W Liu… - JAMA network …, 2023 - jamanetwork.com
Importance Type 2 diabetes (T2D) is associated with the progression of cognitive
dysfunction. Physical activity benefits cognition, but no evidence from randomized clinical …
dysfunction. Physical activity benefits cognition, but no evidence from randomized clinical …
[HTML][HTML] Current and future prevalence estimates of mild cognitive impairment, dementia, and its subtypes in a population-based sample of people 70 years and older …
L Gjøra, BH Strand, S Bergh, T Borza… - Journal of …, 2021 - content.iospress.com
Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its
Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT …
Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT …
[HTML][HTML] Prevalence of dementia in Latin America and Caribbean countries: systematic review and meta-analyses exploring age, sex, rurality, and education as …
F Ribeiro, AC Teixeira-Santos, P Caramelli… - Ageing research …, 2022 - Elsevier
Background Studies have shown that the prevalence of dementia in Latin America and the
Caribbean (LAC) may be higher than in high-income countries. Thus, we sought to …
Caribbean (LAC) may be higher than in high-income countries. Thus, we sought to …
[HTML][HTML] Cholesterol and Alzheimer's disease risk: a meta-meta-analysis
O Sáiz-Vazquez, A Puente-Martínez, S Ubillos-Landa… - Brain sciences, 2020 - mdpi.com
Background: Alzheimer's disease (AD) is the most common subtype of dementia. In the last
ten years, the relationship between cholesterol and AD has been investigated. Evidence …
ten years, the relationship between cholesterol and AD has been investigated. Evidence …
[HTML][HTML] microRNA-based biomarkers in Alzheimer's disease (AD)
Y Zhao, V Jaber, PN Alexandrov, A Vergallo… - Frontiers in …, 2020 - frontiersin.org
Alzheimer's disease (AD) is a multifactorial, age-related neurological disease characterized
by complex pathophysiological dynamics taking place at multiple biological levels, including …
by complex pathophysiological dynamics taking place at multiple biological levels, including …